Literature DB >> 18299155

Generation and behavioral characterization of beta-catenin forebrain-specific conditional knock-out mice.

Todd D Gould1, Kelley C O'Donnell, Alyssa M Picchini, Eliot R Dow, Guang Chen, Husseini K Manji.   

Abstract

The canonical Wnt pathway and beta-catenin have been implicated in the pathophysiology of mood disorders. We generated forebrain-specific CRE-mediated conditional beta-catenin knock-out mice to begin exploring the behavioral implications of decreased Wnt pathway signaling in the central nervous system. In situ hybridization revealed a progressive knock-out of beta-catenin that began between 2 and 4 weeks of age, and by 12 weeks resulted in considerably decreased beta-catenin expression in regions of the forebrain, including the frontal cortex, hippocampus, and striatum. A significant decrease in protein levels of beta-catenin in these brain regions was observed by Western blot. Behavioral characterization of these mice in several tests (including the forced swim test, tail suspension test (TST), learned helplessness, response and sensitization to stimulants, and light/dark box among other tests) revealed relatively circumscribed alterations. In the TST, knock-out mice spent significantly less time struggling (a depression-like phenotype). However, knock-out mice did not differ from their wild-type littermates in the other behavioral tests of mood-related or anxiety-related behaviors. These results suggest that a 60-70% beta-catenin reduction in circumscribed brain regions is only capable of inducing subtle behavioral changes. Alternatively, regulating beta-catenin may modulate drug effects rather than being a model of mood disorder pathophysiology per se.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299155      PMCID: PMC2676732          DOI: 10.1016/j.bbr.2007.12.028

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  40 in total

1.  The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3.

Authors:  C Yost; M Torres; J R Miller; E Huang; D Kimelman; R T Moon
Journal:  Genes Dev       Date:  1996-06-15       Impact factor: 11.361

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol.

Authors:  H J Whitfield; L S Brady; M A Smith; E Mamalaki; R J Fox; M Herkenham
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

4.  A molecular mechanism for the effect of lithium on development.

Authors:  P S Klein; D A Melton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.

Authors:  Todd D Gould; Haim Einat; Ratan Bhat; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2004-07-26       Impact factor: 5.176

6.  Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.

Authors:  W Timothy O'Brien; Amber DeAra Harper; Fernando Jové; James R Woodgett; Silvia Maretto; Stefano Piccolo; Peter S Klein
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

7.  Essential functions of synapsins I and II in synaptic vesicle regulation.

Authors:  T W Rosahl; D Spillane; M Missler; J Herz; D K Selig; J R Wolff; R E Hammer; R C Malenka; T C Südhof
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

8.  In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.

Authors:  Xiaohua Li; Wawa Zhu; Myoung-Sun Roh; Ari B Friedman; Kelley Rosborough; Richard S Jope
Journal:  Neuropsychopharmacology       Date:  2004-08       Impact factor: 7.853

9.  Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior.

Authors:  Cedric Mombereau; Klemens Kaupmann; Wolfgang Froestl; Gilles Sansig; Herman van der Putten; John F Cryan
Journal:  Neuropsychopharmacology       Date:  2004-06       Impact factor: 7.853

10.  Phosphorylation of the Drosophila adherens junction protein Armadillo: roles for wingless signal and zeste-white 3 kinase.

Authors:  M Peifer; L M Pai; M Casey
Journal:  Dev Biol       Date:  1994-12       Impact factor: 3.582

View more
  39 in total

1.  Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.

Authors:  David T Dao; Pamela Belmonte Mahon; Xiang Cai; Colleen E Kovacsics; Robert A Blackwell; Michal Arad; Jianxin Shi; Peter P Zandi; Patricio O'Donnell; James A Knowles; Myrna M Weissman; William Coryell; William A Scheftner; William B Lawson; Douglas F Levinson; Scott M Thompson; James B Potash; Todd D Gould
Journal:  Biol Psychiatry       Date:  2010-08-17       Impact factor: 13.382

2.  Regulation of hippocampus-dependent memory by the zinc finger protein Zbtb20 in mature CA1 neurons.

Authors:  Anjing Ren; Huan Zhang; Zhifang Xie; Xianhua Ma; Wenli Ji; David Z Z He; Wenjun Yuan; Yu-Qiang Ding; Xiao-Hui Zhang; Weiping J Zhang
Journal:  J Physiol       Date:  2012-07-09       Impact factor: 5.182

3.  Learning impairments and molecular changes in the brain caused by β-catenin loss.

Authors:  Robert J Wickham; Jonathan M Alexander; Lillian W Eden; Mabel Valencia-Yang; Josué Llamas; John R Aubrey; Michele H Jacob
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

Review 4.  Validating GSK3 as an in vivo target of lithium action.

Authors:  W Timothy O'Brien; Peter S Klein
Journal:  Biochem Soc Trans       Date:  2009-10       Impact factor: 5.407

Review 5.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

6.  N-cadherin regulates molecular organization of excitatory and inhibitory synaptic circuits in adult hippocampus in vivo.

Authors:  Deanna L Benson; George W Huntley; Jessica S Nikitczuk; Shekhar B Patil; Bridget A Matikainen-Ankney; Joseph Scarpa; Matthew L Shapiro
Journal:  Hippocampus       Date:  2014-04-29       Impact factor: 3.899

Review 7.  Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry.

Authors:  Kimberly A Mulligan; Benjamin N R Cheyette
Journal:  Mol Neuropsychiatry       Date:  2017-01-13

Review 8.  Epigenetic mechanisms of depression and antidepressant action.

Authors:  Vincent Vialou; Jian Feng; Alfred J Robison; Eric J Nestler
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

Review 9.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

10.  Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers.

Authors:  Rulun Zhou; Peixiong Yuan; Yun Wang; Joshua G Hunsberger; Abdel Elkahloun; Yanling Wei; Patricia Damschroder-Williams; Jing Du; Guang Chen; Husseini K Manji
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.